We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Reset all filters
01 20Alfred E Tiefenbacher GmbH
02 5Pharmathen SA
03 7Actavis Inc
04 3Alkem Laboratories
05 6CHEMO
06 9Collegium Pharmaceutical
07 8ENDO OPERATIONS LTD.
08 5GL Pharma
09 38Grunenthal
10 12Grünenthal GmbH
11 11Grünenthal GmbH,
12 2Health Biotech
13 2Hubei Gedian Humanwell Pharmaceutical
14 5Johnson & Johnson Innovative Medicine
15 3Novagen Healthcare
16 10ORIFARM GROUP AS
17 9Orchid Pharma
18 7Precise Group
19 2RHODES PHARMACEUTICALS LP
20 3ROXANE
21 5Sandoz B2B
22 5Seqirus
23 12Spirig Healthcare
24 1Vega Biotech Pvt. Ltd.
25 4West-ward Pharmaceutical Corp
26 24Blank
Reset all filters
01 1Antic-calc Tablet, Film Coated
02 20Depot tablet
03 10Depottablett
04 7ER TABLET
05 4ER Tablet
06 10Extended Release Tablets
07 12Extended-Release Tablet
08 4FILM COATED PILL
09 6Film Coated Tablet
10 1Film-Coated Tablets
11 5Filmtabl
12 1L?s
13 2Mixture, solution
14 2ORAL SOLUTION
15 6PROLONGED-RELEASE TABLET
16 5Prolonged Release Tablet
17 24Ret Tabl
18 2SOLUTION;ORAL
19 12SR Tablet
20 3SRT
21 4Solution
22 2TAB
23 3TABLET
24 5TABLET (EXTENDED-RELEASE)
25 3TABLET (IMMEDIATE RELEASE)
26 14TABLET, EXTENDED RELEASE;ORAL
27 2TABLET; ORAL
28 12TABLET;ORAL
29 14Tablet
30 1Tablet, film-coated
31 1Tapentadolo 100Mg 30 Joined' Oral Use Rp
32 1Tapentadolo 150Mg 30 Joined' Oral Use Rp
33 1Tapentadolo 200Mg 30 Joined' Oral Use Rp
34 1Tapentadolo 250Mg 30 Joined' Oral Use Rp
35 1Tapentadolo 25Mg 40 Combined Oral Use Rp
36 1Tapentadolo 50Mg 30 Joined' Oral Use Rp
37 10XR Tablet
38 5Blank
Reset all filters
01 1DISCN
02 2EU Dossier Readiness-Q1 2020
03 4EU Dossier Readiness-Q3 2019
04 8Generic
05 9Generic EU CTD
06 8Narcotic (CDSA I)
07 5Originator
08 8RX
09 14Status- Early Development
10 12Under registration in India
11 147Blank
Reset all filters
01 160 Palexia Retard 100Mg Extended Release Tablets
02 160 Palexia Retard 150Mg Extended Release Tablets
03 160 Palexia Retard 200Mg Extended Release Tablets
04 160 Palexia Retard 250Mg Extended Release Tablets
05 160 Palexia Retard 25Mg Extended Release Tablets
06 160 Palexia Retard 50Mg Extended Release Tablets
07 160 Yantil Retard 100Mg Extended Release Tablets
08 160 Yantil Retard 150Mg Extended Release Tablets
09 160 Yantil Retard 200Mg Extended Release Tablets
10 160 Yantil Retard 250Mg Extended Release Tablets
11 160 Yantil Retard 25Mg Extended Release Tablets
12 160 Yantil Retard 50Mg Extended Release Tablets
13 4NUCYNTA
14 5NUCYNTA ER
15 5NUCYNTA EXTENDED-RELEASE
16 3NUCYNTA IR
17 35Palexia
18 1Palexia 100 mg
19 1Palexia 50 mg
20 16Palexia Depot
21 5Palexia SR
22 1Palexia SR 100 mg
23 1Palexia SR 200 mg
24 1Palexia SR 50 mg
25 20Palexia depot
26 5TADOMON
27 5TAPELOD
28 16TAPENTADOL
29 5TAPENTADOL HYDROCHLORIDE
30 1Tapencet ER
31 12Tapentadol Spirig HC retard
32 64Blank
Reset all filters
01 5Australia
02 8Canada
03 20Germany
04 5Greece
05 34India
06 16Italy
07 34Norway
08 5South Africa
09 18Spain
10 12Sweden
11 31Switzerland
12 30USA
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany